This article is part of Research Program Identifies Microbiome Biomarkers Implicated in Lung Cancer.
In October 2019, NYU Langone’s Thoracic Medical Oncology Program became the 23rd member of the Thoracic Surgery Oncology Group (TSOG), North America’s premier network for thoracic surgery clinical trials. Membership in TSOG enables enhanced collaborations in the translational and clinical trial components of the Perlmutter Cancer Center research portfolio, nurtured by Kwok-Kin Wong, MD, PhD, the Anne Murnick Cogan and David H. Cogan Professor of Oncology in the Department of Medicine and director of the Division of Hematology and Medical Oncology.